Nebraska Heart Institute is a clinical research site located in Lincoln, Nebraska, United States 68526.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Nebraska Heart Institute has participated in 42 clinical trials with 4 currently active.
Therapeutic areas: Symptomatic Severe Aortic Stenosis, Primary Prevention of Atherosclerotic Cardiovascular Disease, Bradycardia.
Sponsors: Edwards Lifesciences, Novartis Pharmaceuticals, Boston Scientific Corporation.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Heart Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Heart Institute has 42 clinical trials on record, with 4 currently active. Their work covers Symptomatic Severe Aortic Stenosis, Primary Prevention of Atherosclerotic Cardiovascular Disease, Bradycardia.
Nebraska Heart Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.